{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:35:55Z","timestamp":1773369355060,"version":"3.50.1"},"reference-count":36,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Acute pancreatitis (AP) is an uncommon but serious complication in children undergoing treatment for acute leukemia. We aimed to determine the prevalence of AP in pediatric patients with acute leukemia, identify its risk factors, and evaluate their impact on treatment outcomes and overall survival. Materials and Methods: We retrospectively reviewed the medical records of children with acute leukemia who developed acute abdominal pain suggestive of AP at Songklanagarind Hospital between 2004 and 2024. Demographic data, including leukemia subtypes, treatment protocols, and clinical outcomes, were compared between the patients with and without AP. Results: Of the 618 patients with leukemia, 70 children with abdominal pain were identified, and 17 were diagnosed with AP. The prevalence of AP was 2.8%. Most children with acute leukemia and AP had T-cell subtypes (50.0%) and received high- to very-high-risk treatment protocols (76.5%). Patients with AP experienced a shorter duration of abdominal pain before diagnosis and required imaging more frequently than the non-AP patients did (100% vs. 56.6%). They required a prolonged fasting period and greater intravenous fluid volume within 48 h. The overall mortality rate (all-cause during follow-up) was significantly higher in the AP group. Using high- to very-high-risk chemotherapy protocols was a risk factor for AP, and the accumulative L-asparaginase dose of \u226555,200 IU\/m2 could increase AP risk. Conclusions: AP is significantly associated with increased overall mortality in children with acute leukemia. Careful monitoring of L-asparaginase dosing may be required. Larger studies are needed to better identify the risk factors and preventive strategies.<\/jats:p>","DOI":"10.3390\/cancers18060910","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T14:43:18Z","timestamp":1773240198000},"page":"910","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and Risk Factors of Acute Pancreatitis in Childhood Acute Leukemia"],"prefix":"10.3390","volume":"18","author":[{"given":"Kamonluk","family":"Thepuatrakul","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4750-4973","authenticated-orcid":false,"given":"Atchariya","family":"Chanpong","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsaruth","family":"Songthawee","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pornpun","family":"Sripornsawan","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirinthip","family":"Kittivisuit","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hansa","family":"Sriphongphankul","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0111-6318","authenticated-orcid":false,"given":"Thirachit","family":"Chotsampancharoen","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute Lymphoblastic Leukemia in Children","volume":"373","author":"Hunger","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S1470-2045(17)30424-2","article-title":"Asparaginase-Associated Pancreatitis in Childhood Acute Lymphoblastic Leukaemia: An Observational Ponte Di Legno Toxicity Working Group Study","volume":"18","author":"Wolthers","year":"2017","journal-title":"Lancet Oncol."},{"key":"ref_3","first-page":"45","article-title":"Drug-Induced Acute Pancreatitis: A Review","volume":"15","author":"Jones","year":"2015","journal-title":"Ochsner J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(08)60107-5","article-title":"Acute Pancreatitis","volume":"371","author":"Frossard","year":"2008","journal-title":"Lancet"},{"key":"ref_5","first-page":"100357","article-title":"Acute Pancreatitis Following L-Asparaginase in Acute Lymphoblastic Leukemia","volume":"18","author":"Elouali","year":"2022","journal-title":"Leuk. Res. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s40265-022-01766-4","article-title":"Acute Pancreatitis: Diagnosis and Treatment","volume":"82","author":"Szatmary","year":"2022","journal-title":"Drugs"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Morawiak, A., Salamonowicz-Bodzioch, M., Kr\u00f3lak, A., Ka\u0142wak, K., Owoc-Lempach, J., Kowalczyk, J., Zawitkowska, J., Szczepa\u0144ski, T., Irga-Jaworska, N., and Adamkiewicz-Dro\u017cy\u0144ska, E. (2024). Acute Pancreatitis in Pediatric Acute Lymphoblastic Leukemia (AcuPA Study): A Nationwide Survey in Poland. Cancers, 16.","DOI":"10.20944\/preprints202405.1449.v1"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1182\/blood-2019-128236","article-title":"Risk Factors of Acute Pancreatitis in Pediatric Acute Lymphoblastic Leukemia Patients: A Single-Center Experience","volume":"134","author":"MIN","year":"2019","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41390-021-01796-w","article-title":"Acute Pancreatitis in Children with Acute Lymphoblastic Leukemia Correlates with L-Asparaginase Dose Intensity","volume":"92","author":"Chen","year":"2022","journal-title":"Pediatr. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/MPH.0b013e3181b87035","article-title":"Acute Pancreatitis in Children with Acute Lymphoblastic Leukemia after Chemotherapy","volume":"31","author":"Treepongkaruna","year":"2009","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/bjh.12733","article-title":"Asparaginase-Associated Pancreatitis in Children with Acute Lymphoblastic Leukaemia in the NOPHO ALL2008 Protocol","volume":"165","author":"Raja","year":"2014","journal-title":"Br. J. Haematol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Hassan, S., Ahmed, S., Ali, N., Mokhles, A., Zaky, I., Reda, H., Youssef, S.H., Hammad, D., Hassanain, O., and Sidhom, I. (2025). Risk Factors and Outcome of Asparaginase-Associated Pancreatitis in Pediatric Acute Lymphoblastic Leukemia. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1606261"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/MPG.0b013e31824f1516","article-title":"Definitions of Pediatric Pancreatitis and Survey of Present Clinical Practices","volume":"55","author":"Morinville","year":"2012","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1053\/j.gastro.2018.12.043","article-title":"Pancreatitis in Children","volume":"156","author":"Uc","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_15","unstructured":"Cancer Therapy Evaluation Program (2026, February 26). Common Terminology Criteria for Adverse Events (CTCAE) Version 6.0, Published 22 July 2025, Available online: https:\/\/dctd.cancer.gov\/research\/ctep-trials\/for-sites\/adverse-events."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4978456","DOI":"10.1155\/2022\/4978456","article-title":"The Effect of Chemotherapy Induction Therapy on the Pancreas in Patients with Acute Lymphoblastic Leukemia","volume":"2022","author":"Wondmeneh","year":"2022","journal-title":"BioMed Res. Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/mpo.2950140506","article-title":"The Staging of Childhood Acute Lymphoblastic Leukemia: Strategies of the Childrens Cancer Study Group and a Three-Dimensional Technic of Multivariate Analysis","volume":"14","author":"Bleyer","year":"1986","journal-title":"Med. Pediatr. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(88)92596-2","article-title":"Intensive Therapy for Children with Acute Lymphoblastic Leukaemia and Unfavourable Presenting Features. Early Conclusions of Study CCG-106 by the Childrens Cancer Study Group","volume":"2","author":"Gaynon","year":"1988","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1080\/08880018.2023.2188889","article-title":"Treatment Outcomes in Childhood Acute Lymphoblastic Leukemia: 40-Year Experience from a Single Tertiary Center in Thailand","volume":"40","author":"Chavananon","year":"2023","journal-title":"Pediatr. Hematol. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/mpo.1321","article-title":"The Treatment of Children with Acute Lymphoblastic Leukemia in Thailand","volume":"38","author":"Laosombat","year":"2002","journal-title":"Med. Pediatr. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.1993.11.3.527","article-title":"Improved Outcome with Delayed Intensification for Children with Acute Lymphoblastic Leukemia and Intermediate Presenting Features: A Childrens Cancer Group Phase III Trial","volume":"11","author":"Tubergen","year":"1993","journal-title":"J. Clin. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.leu.2402132","article-title":"A Comparison of Early Intensive Methotrexate\/Mercaptopurine with Early Intensive Alternating Combination Chemotherapy for High-Risk B-Precursor Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Phase III Randomized Trial","volume":"15","author":"Lauer","year":"2001","journal-title":"Leukemia"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1200\/JCO.2011.37.8018","article-title":"Improved Survival for Children and Adolescents with Acute Lymphoblastic Leukemia between 1990 and 2005: A Report from the Children\u2019s Oncology Group","volume":"30","author":"Hunger","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1200\/JCO.1996.14.1.18","article-title":"Uniform Approach to Risk Classification and Treatment Assignment for Children with Acute Lymphoblastic Leukemia","volume":"14","author":"Smith","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.31557\/APJCP.2022.23.10.3517","article-title":"Relapsed Childhood Acute Lymphoblastic Leukemia: Experience from a Single Tertiary Center in Thailand","volume":"23","author":"Chotsampancharoen","year":"2022","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1182\/blood.V75.10.1932.1932","article-title":"Identification of Two Risk Groups in Childhood Acute Myelogenous Leukemia after Therapy Intensification in Study AML-BFM-83 as Compared with Study AML-BFM-78. AML-BFM Study Group","volume":"75","author":"Creutzig","year":"1990","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1080\/10428194.2024.2382916","article-title":"Long-Term Survival Outcome of Childhood Acute Myeloid Leukemia: A 43-Year Experience in Thailand, a Resource-Limited Country","volume":"65","author":"Sripornsawan","year":"2024","journal-title":"Leuk. Lymphoma"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1200\/JCO.2006.06.5037","article-title":"Less Toxicity by Optimizing Chemotherapy, but Not by Addition of Granulocyte Colony-Stimulating Factor in Children and Adolescents with Acute Myeloid Leukemia: Results of AML-BFM 98","volume":"24","author":"Creutzig","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/cncr.26190","article-title":"AAML03P1, a Pilot Study of the Safety of Gemtuzumab Ozogamicin in Combination with Chemotherapy for Newly Diagnosed Childhood Acute Myeloid Leukemia: A Report from the Children\u2019s Oncology Group","volume":"118","author":"Cooper","year":"2012","journal-title":"Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.31557\/APJCP.2022.23.12.4079","article-title":"Relapsed Childhood Acute Myeloid Leukemia: Experience from a Single Tertiary Center in Thailand","volume":"23","author":"Songthawee","year":"2022","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/MCG.0000000000000827","article-title":"Risk Factors for Asparaginase-Associated Pancreatitis: A Systematic Review","volume":"51","author":"Oparaji","year":"2017","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/pbc.21037","article-title":"Predicting Asparaginase-Associated Pancreatitis","volume":"49","author":"Knoderer","year":"2007","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1200\/JCO.2015.64.5812","article-title":"Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia","volume":"34","author":"Liu","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JCO.19.02208","article-title":"Asparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia: Results From the NOPHO ALL2008 Treatment of Patients 1-45 Years of Age","volume":"38","author":"Rank","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/MPH.0b013e3181b794e8","article-title":"Acute Pancreatitis in Children with Acute Lymphoblastic Leukemia Treated with L-Asparaginase","volume":"31","year":"2009","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00277-024-06133-9","article-title":"Risk Factors and a Prediction Model of Severe Asparaginase-Associated Pancreatitis in Children","volume":"104","author":"Lin","year":"2025","journal-title":"Ann. Hematol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/6\/910\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:08:36Z","timestamp":1773328116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/6\/910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["cancers18060910"],"URL":"https:\/\/doi.org\/10.3390\/cancers18060910","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]}}}